MMS22L and metastatic malignant neoplasm in the lymph nodes: Additionally, among the various clinicopathological characteristics evaluated, no significant associations were found between the MMS22L expression level and age, sex, differentiation, location, depth of invasion, or TNM clinical stage, but a low expression level of MMS22L was markedly associated with lymph node metastasis (p < 0.01; Table 2).